Drug Profile
WPP 201
Alternative Names: WPP-201Latest Information Update: 03 May 2016
Price :
$50
*
At a glance
- Originator Intralytix
- Class Anti-infectives; Viruses
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Leg ulcer
Most Recent Events
- 03 May 2016 No recent reports on development identified - Phase-I for Leg ulcer in USA (Topical)